Context Stereotactic ablative body radiotherapy (SABR) is an emerging treatment modality
for primary and metastatic renal cell carcinoma (RCC). Objective To review and summarise …

Renal cell carcinoma (RCC) is recognized as one of the three primary malignant tumors
affecting the urinary system, posing a significant risk to human health and life. Despite …

Radiotherapy (RT) has been reported to induce abscopal effect in advanced hepatocellular
carcinoma (HCC), but such phenomenon was only observed in sporadic cases. Here, we …

Radiotherapy (XRT) is often utilized to improve the immune checkpoint blockade response
in cancer management. Such combination treatment can enhance the abscopal effect …

Radiotherapy is a very effective cancer treatment, mainly through inducing DNA damage of
cancer cells. Meanwhile, there is evidence that irradiation can also mobilize tumor-specific …

Background Surgery remains the standard of care for localised renal cell carcinoma (RCC).
Nevertheless, nearly 50% of patients with high-risk disease experience relapse after …

The combination of targeted therapy and immunotherapy in the treatment of metastatic renal
cell carcinoma (mRCC) has significantly improved outcomes for many patients. There are …

Background Kidney cancer is a significant global health problem that affects nearly 1 in 25 of
cancer patients. Prevalence, morbidity and mortality data associated with kidney cancer …

Stereotactic ablative radiotherapy (SABR) has challenged the conventional wisdom
surrounding the radioresistance of renal cell carcinoma (RCC). In the past decade, there has …

(1) We hypothesized that adding concurrent stereotactic ablative radiotherapy (SAbR) would
increase the time to progression in patients with metastatic castrate-resistant prostate cancer …